Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.090
-0.050 (-4.39%)
At close: Apr 25, 2025, 4:00 PM
1.100
+0.010 (0.92%)
After-hours: Apr 25, 2025, 5:03 PM EDT
PACB Employees
Pacific Biosciences of California had 575 employees as of December 31, 2024. The number of employees decreased by 221 or -27.76% compared to the previous year.
Employees
575
Change (1Y)
-221
Growth (1Y)
-27.76%
Revenue / Employee
$267,850
Profits / Employee
-$538,871
Market Cap
324.66M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
PACB News
- 3 days ago - Davos Alzheimer's Collaborative Selects PacBio as Technology Partner for Global Project to Advance Alzheimer's Disease Research in North Africa - GlobeNewsWire
- 16 days ago - PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million - GlobeNewsWire
- 21 days ago - PacBio Grants Equity Incentive Award to New Employee - GlobeNewsWire
- 4 weeks ago - Pacific Biosciences Names Jim Gibson Chief Financial Officer - Market Watch
- 4 weeks ago - Jim Gibson to join PacBio as Chief Financial Officer - GlobeNewsWire
- 5 weeks ago - Scientists Solve One of Genomics' Biggest Challenges by Using HiFi Sequencing to Distinguish Highly Similar Paralogous Genes - GlobeNewsWire
- 2 months ago - Pacific Biosciences: Uncertain Federal Research Funding Latest Blow For Already-Battered Stock - Seeking Alpha
- 2 months ago - PacBio to Participate in TD Cowen's 45th Annual Health Care Conference - GlobeNewsWire